Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C)

Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C)

Objective The goal of this work is to evaluate if there is an increase in the risk of thromboembolic events (TEEs) due to concomitant exposure to dexamethasone and apixaban or rivaroxaban. Direct oral anticoagulants (DOACs), as well as corticosteroid dexamethasone, are commonly used to treat individ...

Full description

Bibliographic Details
Main Authors: Charles E Leonard, Ainhoa Gomez-Lumbreras, Daniel C Malone, Kathleen M Andersen, G Caleb Alexander, Olga V Kravchenko, Richard D Boyce, Paul T Kocis, Lorenzo Villa Zapata, Malinda Tan, Hemalkumar Mehta
Format: Article
Language:English
Published: BMJ Publishing Group 2022-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/12/e066846.full

Internet

https://bmjopen.bmj.com/content/12/12/e066846.full

Similar Items